High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Open Access
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (3) , 353-356
- https://doi.org/10.1023/a:1011132609055
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II studyAnnals of Oncology, 2000
- Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancerAnnals of Oncology, 1999
- Central nervous system progression of metastatic breast cancer in patients treated with paclitaxelCancer, 1995
- Response of brain metastases from breast cancer to systemic chemotherapyCancer, 1992
- Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancerCancer, 1987
- Chemotherapy induces regression of brain metastases in breast carcinomaCancer, 1986
- Central nervous system metastasis from breast carcinoma autopsy studyCancer, 1983
- Brain metastases in breast cancer patients receiving adjuvant chemotherapyCancer, 1982
- Reporting results of cancer treatmentCancer, 1981
- The natural history of breast cancer patients with brain metastasesCancer, 1979